OlloBot Reveals OlloNi SS1's New Identity Design and Announces Ollo-Family Blind Box Launch at Houston Pop-Up This July
NEW YORK, July 10, 2026 /PRNewswire/ -- OlloBot unveiled the core upgrades of the OlloNi SS1, marking a comprehensive leap forward in design and AI capabilit for its highly anticipated family companion cyber-pet robot. At the same time, OlloBot has...
e& Announces USD 5.95 Billion Sale of Vodafone Investment
ABU DHABI, UAE, July 10, 2026 /PRNewswire/ -- Following a comprehensive strategic review of its international investment portfolio, Emirates Telecommunications Group Company PJSC ("e&") announced the termination of its Relationship Agreement...
Infiniti Indah Announces the Return of Pesta Kuantan 188 from 31 July to 2 August.
Bringing 14 Exciting Event Experiences for the People Expecting to draw more than 100,000 local, domestic and international visitors KUANTAN, Malaysia, July 9, 2026 /PRNewswire/ -- Infiniti Indah Sdn. Bhd. (Kuantan 188), a subsidiary of Trinidad...
InxMed Announces Publication in The Lancet Respiratory Medicine Featuring Promising Anticancer Activity of Ifebemtinib in combination with Garsorasib in First-Line non-small cell lung cancer (NSCLC) Harboring KRAS G12C Mutation
NANJING, China, July 9, 2026 /PRNewswire/ -- InxMed Co., Ltd ("InxMed"), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting cancer treatment resistance and metastasis, today announced that the clinical...
RoboSense Announces H1 2026 LiDAR Sales of 719,200 Units as Robotics Segment Grows by 510.4%
RoboSense recorded 719,200 units in LiDAR sales in H1 2026, up 169.6% year over year, with robotics LiDAR sales surging 510.4% to 282,600 units. In Q2 2026, RoboSense recorded 388,900 units in LiDAR sales, including 97,100 units from robotics...
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
HANGZHOU, China, SHANGHAI and BOSTON, July 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the...
Pop Culture Group Co., Ltd Announces 10 for 1 Share Consolidation
XIAMEN, China, July 9, 2026 /PRNewswire/ -- Pop Culture Group Co., Ltd (NASDAQ: CPOP) (the "Company"), today announced that it will effect a share consolidation of its Class A ordinary shares of par value US$0.01 each (the "Class A Ordinary...
Yatsen Group Announces Partnership with Sephora China, Cementing Position as a Science-Led Beauty Innovation Leader
GUANGZHOU, China, July 8, 2026 /PRNewswire/ -- Yatsen Group (NYSE: YSG), a world-class beauty innovation pioneer, recently announced a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership...
Bambu Lab Announces 48-Hour Charity Fundraiser to Support Venezuela Earthquake Relief
AUSTIN, Texas, July 8, 2026 /PRNewswire/ -- Building on the ongoing relief efforts of Bambu Lab LATAM, including a USD 50,000 contribution toward earthquake recovery in Venezuela, Bambu Lab today announced a further step: a 48-hour community...
Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib
SHANGHAI, July 7, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...